Ann: Appendix 4D & Half-Year Financial Statements, page-68

How’s Ross?

I wondered the same thing yesterday @ around 10:35 am when CYP's biggest competitor released its announcement to the market ? Maybe this shot was snapped at CYP HQ yesterday ? lol





Seriously though, Cynata's phase 2 FDA GVHD trial might struggle to secure a USA partner now leaving the funding requirements for CYP itself to come up with .... looking like a heavily discounted CR might be on the way at these levels, which would severely dilute current shareholders ....

..... and adding (say) 50 million shares @ 25 cents to the current SOI might see some even slip from the T20 list if that happens